What are you looking for? Search Common searches: Departments, Hospitalisation, Professionals, Outpatient clinics, Health advice, Accreditations, Diseases, Diagnostic tests, Treatments, The birth of a child, Emergency, Visiting patients, Fulltext search Tipus de contingut Services and units Professionals Pathologies Health advices Health and wellness Diagnostic tests Treatments News Activities Centers - Any - Search News AI based solutions and advanced digital technologies to revolutionise stroke care in Europe UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care. News European Partnership Opens a New Era in Rare Disease Research The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond. News Vall d'Hebron identifies one of the mechanisms that allows HIV control without treatment A study by the Infectious Diseases group at VHIR has found that some people with HIV can uniquely control the virus thanks to a special type of cell in their immune system. News An innovative simulator created in Vall d'Hebron helps to train professionals in ECMO Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique. News Two Vall d'Hebron projects receive the 2024 Gilead Biomedical Research Grants The awarded projects will study the immune response to HIV and the VIGex tool as a biomarker for immunotherapy response. Professionals Josep Quer Sivila I am a senior researcher at VHIR, specializing in Virology. Since 1989, I have focused my studies on research regarding the infection by the Hepatitis C virus (HCV), with a special emphasis on viral diversity. In 1992, I participated in the first description of the quasispecies nature of HCV. Since Activities III Curso Impacto de las nuevas Tecnologías en el Control de la Diabetes Aula Vall d'Hebron Secretaría Técnica actividades formativas externas Mail: inscripcions@aulavallhebron.cat tel: 693.785.436 Professionals Estela Villanueva Villanueva As the Head of Talent Attraction and Acquisition at the Vall Hebron Institute of Research, I bring over a decade of expertise in recruitment, with a specialized focus on the healthcare and biomedical research sectors for the past four years. Professionals Judit Prat Trunas I am a predoctoral researcher in the Diagnostic Nanotools group. My job entails the development of rapid diagnostic assays for infectious diseases. News The importance of scientific communication rigor and creating impactful campaigns kick off the 1st International Health Communication Congress More than 400 professionals from the fields of health, communication, and political institutions exchange reflections and experiences. Experts warn about the impact of misinformation and the need for transparent and effective communication Pagination Previous page ‹‹ Page 234 Next page ››